-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Sequencing Bispecific Antibodies and CAR T-cells for FL

Program: Education Program
Session: Follicular Lymphoma: Playing the Long Game
Hematology Disease Topics & Pathways:
Education
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Nancy L. Bartlett, MD

Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO; Siteman Cancer Center, Washington University Sch. of Medicine, Saint Louis, MO

Disclosures: Bartlett: ADC Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Autolus: Research Funding; BMS/Celgene: Research Funding; Forty Seven/Gilead: Research Funding; Janssen: Research Funding; Millennium: Research Funding; Pharmacyclics: Research Funding; Roche/Genetech: Membership on an entity's Board of Directors or advisory committees, Research Funding; Seattle Genetics: Research Funding; Foresight Diagnositcs: Membership on an entity's Board of Directors or advisory committees; Genmab/AbbVie: Membership on an entity's Board of Directors or advisory committees, Research Funding; Kite: Membership on an entity's Board of Directors or advisory committees; Gilead/Kite Pharma: Research Funding.

See more of: Follicular Lymphoma: Playing the Long Game
See more of: Education Program
<< Previous Presentation | Next Presentation